Pharmaceutical

Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populationsFDA clearance of IND application triggered a US$...

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). Mitigates...

Precise Introduces the First Unified Behavioral Health Operating System BOS Servicing the Complete Care Continuum

Designed by clinicians for clinicians, BOS improves clinical outcomes, financial performance, and value-based care results. LOS ANGELES, CA / ACCESS...

error: Content is protected !!